In 2005, Merck and the Government of China established the first large-scale comprehensive public/private partnership known as the China-MSD HIV/AIDS Partnership (CMAP), to address HIV and AIDS prevention, patient care, treatment and support. In support of "China's Action Plan for Reducing & Preventing the spread of HIV/AIDS (2006-2010)", the partners introduced the Project in Liangshan Prefecture, Sichuan Province, with the aim of developing a comprehensive model that could be replicated in other provinces.
C-MAP is led by two co-national directors and has project offices in Beijing, Sichuan Province and Liangshan Prefecture.
The project is focused on six goals:
- Raising awareness and reducing discrimination among target populations through training and education;
- Deploying comprehensive, integrated risk-reduction approaches to reduce HIV transmission among high-risk populations;
- Establishing a service network to provide consecutive treatment, care and support to people living with HIV and AIDS;
- Providing support to orphans and families affected by HIV to alleviate negative social and economic impacts;
- Building capacity of health care workers and organizations and developing new anti-HIV strategies and techniques; and
- Strengthening HIV surveillance, monitoring and evaluation systems and data management and analysis to track program implementation, assess program outcomes, and identify and apply best practices in a timely manner.
C-MAP collaborates closely with around 11,500 people working in 1,600 implementing organizations, including departments within the Government of China, medical and health institutions, civil societies, international organizations, grassroots healthcare workers, and beneficiary groups.
The Merck Company Foundation has committed $30 million to support the partnership over five years. The Government of China, through the leadership of the Ministry of Health, is providing staff, facilities and equipment.
The content on this page was last modified on September 15, 2009.
Merck & Co., Inc., Whitehouse Station, NJ, USA, and Schering-Plough Corporation, Kenilworth, NJ, USA, are now one company. We have combined our global operations under the name Merck & Co., Inc. We are working to update our corporate responsibility Web site to reflect our new, combined, global organization.